REATA PHARMACEUTICALS INC Operating Lease Right-of-Use Assets
REATA PHARMACEUTICALS INC had Operating Lease Right-of-Use Assets of $78.60 million as of 2023-06-30, per its 10-Q filed 2023-08-08.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2023-08-08
- 2023-06-30: Operating Lease, Right-of-Use Asset $78.60M.
- 2023-03-31: Operating Lease, Right-of-Use Asset $103.81M.
- 2022-12-31: Operating Lease, Right-of-Use Asset $105.26M.
- 2022-09-30: Operating Lease, Right-of-Use Asset $127.14M.
| Period end | Operating Lease, Right-of-Use Asset | Operating Lease, Right-of-Use Asset as first filed |
|---|---|---|
| 2023-06-30 | $78.60M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $103.81M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $105.26M 10-Q · filed 2023-08-08 | |
| 2022-09-30 | $127.14M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $129.16M 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $131.18M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $126.78M 10-K · filed 2023-02-24 | |
| 2021-09-30 | $3.07M 10-Q · filed 2021-11-08 | |
| 2021-06-30 | $3.80M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $4.51M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $5.21M 10-K · filed 2022-02-28 | |
| 2020-09-30 | $1.17M 10-Q · filed 2021-11-08 | |
| 2020-06-30 | $7.65M 10-Q · filed 2021-08-09 | |
| 2020-03-31 | $8.37M 10-Q · filed 2021-05-06 | |
| 2019-12-31 | $9.07M 10-K · filed 2021-03-01 | |
| 2019-09-30 | $8.26M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $8.98M 10-Q · filed 2019-08-08 | |
| 2019-01-01 | $1.50M 10-K · filed 2021-03-01 | $1.54M 10-Q · filed 2019-05-09 |